FTC lawsuit claims drug middlemen are manipulating insulin market
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have engaged in anticompetitive practices that spur price increases, the
FTC sues prescription drug middlemen, alleging they conspired over high insulin costs
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns the companies are artificially inflating the list price of insulin drugs.
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.
FTC sues big 3 PBMs for ‘artificially inflated’ insulin prices caused by ‘perverse’ rebating
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to pay more for insulin.
FTC sues top three pharmacy middlemen over insulin prices
The Federal Trade Commission on Friday filed a lawsuit over insulin prices against the three largest pharmaceutical middlemen that negotiate prescription drug prices, arguing that the companies artificially inflate the costs of the lifesaving diabetes drug for patients.
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission alleges CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx created a system that prioritizes high rebates from drug manufacturers, leading to artificially high insulin list prices.
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
FTC sues pharmaceutical middlemen, claiming practices inflated insulin cost
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming unfair practices inflated the cost of insulin.
Modern Healthcare2d
FTC targets 3 biggest PBMs over insulin rebates
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
Sierra Sun Times8h
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, Optum and Affiliates
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...
Federal regulators sue three pharmacy benefit managers over high insulin prices
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
wbng2d
FTC sues over allegedly inflated insulin prices
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
High insulin prices spur federal lawsuit against 3 pharmacy benefit managers
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...